Clinical Trials · NCT04560998
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 792
- Start date
- Oct 2020
- Locations
- 283 sites, 21 countries
- Primary endpoint
- Change in Maximum Walking Distance on a Constant Load Treadmill Test